Sign in to continue:

Monday, March 9th, 2026

Centurion Corp & Coliwoo Holdings: Singapore Retail Investment Insights and Technical Analysis – January 2026 2

Broker: CGS International

Date of Report: January 15, 2026

Excerpt from CGS International report.

  • Japanese Prime Minister Sanae Takaichi plans a snap election to solidify her leadership and secure public support for a new ruling coalition, focusing on proactive fiscal spending and a review of Japan’s defense strategy.
  • Coliwoo Holdings is expanding its presence in Singapore’s affordable central rental market for non-residents, supported by high occupancy, recurring cash flows, and a strong growth pipeline. It currently trades at a significant discount to global peers despite robust return metrics.
  • Centurion Corp Ltd is recommended as a technical buy after ending its corrective structure, with several technical indicators signaling further upside potential. The company specializes in purpose-built workers and student accommodation assets.

Report Summary

  • Japanese snap election aims to cement leadership and boost pro-stimulus policies, with market expectation for continued fiscal support and stable monetary policy.
  • Coliwoo Holdings and Centurion Corp recommended for growth, with Centurion showing renewed technical strength and Coliwoo capitalizing on Singapore’s rental market shortage.

Above is an excerpt from a report by CGS International. Clients of CGS International can be the first to access the full report from the CGS International website: https://www.cgs-cimb.com

Market Insights and Investment Strategies: Spotlight on Delfi Limited, Frasers Logistics Trust, and Other Leading SGX Stocks

In a detailed examination of the Singapore financial markets, Lim & Tan Securities (LTS) has provided a comprehensive investment report focusing on key stocks within the SGX. This analysis highlights companies like Delfi Limited,...

NIO Inc. (NYSE: NIO) – Bottoming Out, Technical Buy

NIO Inc. (NYSE: NIO) – Bottoming Out, Technical Buy Recommendation: Technical Buy Entry Prices: $4.90, $4.31, $4.00 Stop Loss: $3.49 Target Prices: $5.50, $6.60, $7.00, $7.80 Date of Recommendation: September 9, 2024 Broker Company:...

CSPC Pharmaceutical Set for Growth in 2025: Three US$5bn+ BD Deals Expected, Innovative Pipeline Undervalued 1

Broker: China Galaxy International Securities (Hong Kong) Co., Limited Date of Report: May 30, 2025 CSPC Pharmaceutical: Innovative Pipeline Ignites Growth Prospects with Over \$15 Billion in BD Deals Expected in 2025 Executive Summary:...

   Ad